AKT1 and glioblastoma: Using in vitro models, we found that LN18 and LN229 ObR-positive GBM cells respond to leptin with cell growth and induction of the oncogenic pathways of Akt and STAT3, as well as inactivation of the cell cycle suppressor Rb [35].